Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Malone

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Journal of the American Heart Association|September 30, 2023
Sleep Variability, Eating Timing Variability, and Carotid Intima-Media Thickness in Early AdulthoodElissa K Hoopes, Melissa A Witman, Michele N D'Agata, et al.
Veterinary and Comparative Oncology|August 10, 2010
Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumoursE K Malone, K M Rassnick, J J Wakshlag, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2024
Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A Six-Month AnalysisJohn B Tillman, Roy W Beck, William H Polonsky, et al.
Seminars in Hearing|February 19, 2024
Age-Related Changes in Temporal Binding Involving Auditory and Vestibular InputsAlexander K Malone, Michelle E Hungerford, Spencer B Smith, et al.
Diabetes Care|July 12, 2014
Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetesMichaela Diamant, Michael A Nauck, Rimma Shaginian, et al.
Veterinary and Comparative Oncology|June 29, 2010
A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumoursK M Rassnick, D B Bailey, D S Russell, et al.
Pediatric Endocrinology Reviews : PER|March 26, 2020
Eli Lilly and Company Insulins - A Century of InnovationJ K Malone, J H Jr Anderson, H A Wolpert, et al.
Contemporary Clinical Trials|May 22, 2014
Harm reduction with pharmacotherapy for homeless people with alcohol dependence: protocol for a randomized controlled trialSusan E Collins, Andrew J Saxon, Mark H Duncan, et al.
Veterinary and Comparative Oncology|November 11, 2010
Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogsK M Rassnick, D B Bailey, E K Malone, et al.
Clinical and Translational Science|April 27, 2018
Global Standards to Expedite Learning From Medical Research DataLynn D Hudson, Rebecca D Kush, Eileen Navarro Almario, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Journal of the American Heart Association|September 30, 2023
Sleep Variability, Eating Timing Variability, and Carotid Intima-Media Thickness in Early AdulthoodElissa K Hoopes, Melissa A Witman, Michele N D'Agata, et al.
Veterinary and Comparative Oncology|August 10, 2010
Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumoursE K Malone, K M Rassnick, J J Wakshlag, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2024
Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A Six-Month AnalysisJohn B Tillman, Roy W Beck, William H Polonsky, et al.
Seminars in Hearing|February 19, 2024
Age-Related Changes in Temporal Binding Involving Auditory and Vestibular InputsAlexander K Malone, Michelle E Hungerford, Spencer B Smith, et al.
Diabetes Care|July 12, 2014
Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetesMichaela Diamant, Michael A Nauck, Rimma Shaginian, et al.
Veterinary and Comparative Oncology|June 29, 2010
A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumoursK M Rassnick, D B Bailey, D S Russell, et al.
Pediatric Endocrinology Reviews : PER|March 26, 2020
Eli Lilly and Company Insulins - A Century of InnovationJ K Malone, J H Jr Anderson, H A Wolpert, et al.
Contemporary Clinical Trials|May 22, 2014
Harm reduction with pharmacotherapy for homeless people with alcohol dependence: protocol for a randomized controlled trialSusan E Collins, Andrew J Saxon, Mark H Duncan, et al.
Veterinary and Comparative Oncology|November 11, 2010
Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogsK M Rassnick, D B Bailey, E K Malone, et al.
Clinical and Translational Science|April 27, 2018
Global Standards to Expedite Learning From Medical Research DataLynn D Hudson, Rebecca D Kush, Eileen Navarro Almario, et al.
Pageof 13